Increasing Prevalence of Cardiovascular Diseases to Augment Growth of Acute Heart Failure (AHF) Therapeutics Market
Acute heart failure is a medical emergency that involves sudden, permanent cessation of cardiac function (also called ventricular fibrillation). Acute heart failure most often develops due to a rupture or leaky blood vessel somewhere in the heart. This can happen either at the heart site itself, such as at the coronary artery, or at the lung level, such as at the aortic valve. As a result of the rupture, blood is pooling at the heart site and the blood flow is markedly reduced. As this pooling continues, blood pressure drops causing a decrease in cardiac output and, as the problem worsens, shock and death occur. Market Dynamics Increasing prevalence of cardiovascular diseases is expected to propel growth of the global acute heart failure (AHF) therapeutics market. For instance, according to the American Heart Association's Heart and Stroke Statistics 2020 Update, by 2035, 45.1% of the U.S population is projected to have some form of cardiovascular disease. Moreover, increasin...